Inotek Pharmaceuticals Corporation Email Format
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
Inotek Pharmaceuticals was formerly a clinical-stage, publicly traded, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye. The company merged with Rocket Pharma in January 2018.